Cargando…

The future of cancer immunotherapy for brain tumors: a collaborative workshop

Harnessing the effector mechanisms of the immune system to combat brain tumors with antigen specificity and memory has been in research and clinical testing for many years. Government grant mechanisms and non-profit organizations have supported many innovative projects and trials while biotech compa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Christine E., Bucktrout, Samantha, Butterfield, Lisa H., Futer, Olga, Galanis, Evanthia, Hormigo, Adilia, Lim, Michael, Okada, Hideho, Prins, Robert, Marr, Sara Siebel, Tanner, Kirk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Meeting Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125824/ https://www.ncbi.nlm.nih.gov/pubmed/35606815 http://dx.doi.org/10.1186/s12967-022-03438-z

Ejemplares similares

Workshop on immunotherapy combinations. Society for immunotherapy of cancer annual meeting Bethesda, November 3, 2011
por: Forero, Ivan Martinez, et al.
Publicado: (2012)

The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy
por: Desland, Fiona A., et al.
Publicado: (2020)

The Great Debate at ‘Immunotherapy Bridge’, Naples, December 5, 2019
por: Ascierto, Paolo A, et al.
Publicado: (2020)

Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop
por: Marciscano, Ariel E., et al.
Publicado: (2018)

Proceedings of the 2016 China Cancer Immunotherapy Workshop: Beijing, China. 25-26 June 2016
por: Xue, Bin, et al.
Publicado: (2016)

Workshop on challenges, insights, and future directions for mouse and humanized models in cancer immunology and immunotherapy: a report from the associated programs of the 2016 annual meeting for the Society for Immunotherapy of cancer
por: Zloza, Andrew, et al.
Publicado: (2017)

Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al
por: Chheda, Zinal S, et al.
Publicado: (2023)

Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
por: Iwamoto, Fabio M., et al.
Publicado: (2014)

International workshop on the future of community child healthcare
por: Grossman, Zachi, et al.
Publicado: (2019)

Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
por: Bucktrout, Samantha L., et al.
Publicado: (2018)

ILO - Concept and vision of future collaboration
por: Bruant Gulejova, Barbora
Publicado: (2018)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
por: Ahn, Brian J., et al.
Publicado: (2013)

Current Advances in Immunotherapy for Glioblastoma
por: Mende, Abigail L., et al.
Publicado: (2021)

Canola/Rapeseed Protein: Future Opportunities and Directions—Workshop Proceedings of IRC 2015
por: Campbell, Lisa, et al.
Publicado: (2016)

The “Great Debate” at Immunotherapy Bridge 2020, December 3rd, 2020
por: Ascierto, Paolo A., et al.
Publicado: (2021)

A series of NSAID-induced anaphylactic response to immunotherapy and a proposal to include NSAIDS avoidance in future immunotherapy guidelines
por: Chen, Jennifer YF, et al.
Publicado: (2014)

Imaging referral guidelines in Europe: now and in the future—EC Referral Guidelines Workshop Proceedings
por: Remedios, Denis, et al.
Publicado: (2013)

Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience
por: Lee, Eudocia Q, et al.
Publicado: (2021)

Immunotherapy biomarkers 2016: overcoming the barriers
por: Gulley, James L., et al.
Publicado: (2017)

Moving from information and collaboration to action: report from the 4th international dog health workshop, Windsor in May 2019
por: Pegram, Camilla L., et al.
Publicado: (2020)

Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge” (December 4th–5th, 2019, Naples, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2021)

Current status and future challenges of genotoxicity OECD Test Guidelines for nanomaterials: a workshop report
por: Doak, Shareen H, et al.
Publicado: (2023)

Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma
por: Gallus, Marco, et al.
Publicado: (2023)

The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021
por: Ascierto, Paolo A., et al.
Publicado: (2022)

Focus on the target: the tumor microenvironment, Society for Immunotherapy of Cancer Annual Meeting Workshop, October 24th-25th 2012
por: Sunay, Melek Erdinc, et al.
Publicado: (2013)

Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapy
por: Sonabend, Adam M., et al.
Publicado: (2021)

A Summary Report of FSCJ Workshop “Future Challenges and Opportunities in Developing Methodologies for Improved Human Risk Assessments”
por: Tachibana, Kaoruko, et al.
Publicado: (2019)

Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting
por: Vieira de Castro, Joana, et al.
Publicado: (2020)

Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy
por: Chuntova, Pavlina, et al.
Publicado: (2019)

Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR
por: Bayless, Nicholas L, et al.
Publicado: (2021)

A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies
por: Bot, Adrian, et al.
Publicado: (2012)

Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance)
por: Galanis, Evanthia, et al.
Publicado: (2022)

Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancement
por: Connelly, Jennifer, et al.
Publicado: (2016)

Collaboration, workshops, and symposia
por: Pulst, Stefan M.
Publicado: (2017)

A Report from a Workshop of the International Stem Cell Banking Initiative, Held in Collaboration of Global Alliance for iPSC Therapies and the Harvard Stem Cell Institute, Boston, 2017
por: Kim, Jung‐Hyun, et al.
Publicado: (2019)

Allergen immunotherapy
por: Crisafulli, Giuseppe, et al.
Publicado: (2014)

Workshop on The Epidemiology of the ATM Gene: Impact on Breast Cancer Risk and Treatment, Present Status and Future Focus, Lillehammer, Norway, 29 June 2002
por: Bernstein, Jonine L, et al.
Publicado: (2002)

WORKSHOP “PHYSICS FOR HEALTH IN EUROPE”
por: CERN. Geneva
Publicado: (2010)

Epigenetics of gastrointestinal diseases: notes from a workshop
por: Marks, David L., et al.
Publicado: (2018)

The Role of the Gut Microbiome in Cancer Immunotherapy: Current Knowledge and Future Directions
por: Kiousi, Despoina E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_llosg397l9nfnkau4bbe606vpt